Titova N - Search Results

1

'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine.

Rota S, Boura I, Batzu L, Titova N, Jenner P, Falup-Pecurariu C, Chaudhuri KR. Rota S, et al. Among authors: titova n. Expert Rev Neurother. 2020 Sep;20(9):953-965. doi: 10.1080/14737175.2020.1806059. Epub 2020 Sep 15. Expert Rev Neurother. 2020. PMID: 32755243 Review.

2

[Current possibilities of quality of life improvement in the late stages of Parkinson's disease].

Titova NV, Katunina EA. Titova NV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(3):94-100. doi: 10.17116/jnevro20151153194-100. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26171484 Review. Russian.

3

[Dopamine receptor agonists: new forms and new possibilities in the treatment of Parkinson's disease].

Katunina EA, Titova NV, Bezdolny YN, Shykkerimov RK, Gasanov MG, Burd SG, Lebedeva AV, Boiko AN. Katunina EA, et al. Among authors: titova nv. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(5):34-40. doi: 10.17116/jnevro20151155134-40. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26356158 Russian.

4

[A current view on dopamine receptor agonists in the treatment of Parkinson's disease].

Titova NV. Titova NV. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(9):76-83. doi: 10.17116/jnevro20151159176-83. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26525820 Review. Russian.

5

[Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors].

Titova NV, Katunina EA, Sotnikova NN. Titova NV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(4):90-99. doi: 10.17116/jnevro20161164190-99. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 27386592 Review. Russian.

6

Apomorphine therapy in Parkinson's and future directions.

Titova N, Chaudhuri KR. Titova N, et al. Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S56-S60. doi: 10.1016/j.parkreldis.2016.11.013. Epub 2016 Nov 30. Parkinsonism Relat Disord. 2016. PMID: 27913125 Review.

7

Parkinson's: a syndrome rather than a disease?

Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Titova N, et al. J Neural Transm (Vienna). 2017 Aug;124(8):907-914. doi: 10.1007/s00702-016-1667-6. Epub 2016 Dec 27. J Neural Transm (Vienna). 2017. PMID: 28028643 Free PMC article. Review.

8

Intrajejunal levodopa infusion therapy for Parkinson's disease: practical and pragmatic tips for successful maintenance of therapy.

Titova N, Ray Chaudhuri K. Titova N, et al. Expert Rev Neurother. 2017 Jun;17(6):529-537. doi: 10.1080/14737175.2017.1317595. Epub 2017 Apr 17. Expert Rev Neurother. 2017. PMID: 28406336 Review.

9

Biomarkers of Parkinson's Disease: An Introduction.

Titova N, Qamar MA, Chaudhuri KR. Titova N, et al. Int Rev Neurobiol. 2017;132:183-196. doi: 10.1016/bs.irn.2017.03.003. Epub 2017 May 3. Int Rev Neurobiol. 2017. PMID: 28554407 Review.

10

The Nonmotor Features of Parkinson's Disease.

Titova N, Qamar MA, Chaudhuri KR. Titova N, et al. Int Rev Neurobiol. 2017;132:33-54. doi: 10.1016/bs.irn.2017.02.016. Epub 2017 Apr 4. Int Rev Neurobiol. 2017. PMID: 28554413 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page